Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record.

Treatment of Type II Gastric Carcinoid Tumors with Somatostatin Analogues

Open access
Tomassetti, Paola, Migliori, Marina, Caletti, Gian Carlo, Fusaroli, Pietro, Corinaldesi, Roberto, Gullo, Lucio·2000·New England Journal of Medicine

Abstract

Gastric carcinoid tumors are rare tumors that originate from gastric enterochromaffin-like cells in the oxyntic mucosa.1 There are three types of gastric carcinoid tumors: type I is associated with chronic atrophic gastritis, type II develops in patients with combined multiple endocrine neoplasia type 1 and the Zollinger–Ellison syndrome, and type III is sporadic.1 Although the pathogenesis of these tumors is not completely understood, hypergastrinemia has an important role in the development of types I and II.2 The multiple endocrine neoplasia type 1 gene locus may be involved in type II gastric carcinoid tumors.3,4 All three types are usually removed . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm200008243430805

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 166

Metadata

Authors
Tomassetti, P., Migliori, M., Caletti, G. C., Fusaroli, P., Corinaldesi, R., & Gullo, L.
Venue
New England Journal of Medicine
Published
2000-08-24
Volume
343
Issue
8
Pages
551-554
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1987953456
Cited by
166
References
0
FWCI
5.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of Type II Gastric Carcinoid Tumors with Somatostatin Analogues. https://app.cochat.ai/papers/10.1056/nejm200008243430805
The paper
Tomassetti, P., Migliori, M., Caletti, G. C., Fusaroli, P., Corinaldesi, R., & Gullo, L. (2000). Treatment of Type II Gastric Carcinoid Tumors with Somatostatin Analogues. New England Journal of Medicine. https://doi.org/10.1056/nejm200008243430805

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.